2-哌嗪甲酸乙酯二盐酸盐
|
K037012-1g
|
97% |
129798-91-0 |
1g
|
¥ 1078.0
|
5-7天 |
科威 |
2-哌嗪甲酸乙酯二盐酸盐
|
K037012-250mg
|
97% |
129798-91-0 |
250mg
|
¥ 449.0
|
5-7天 |
科威 |
5-三氟甲基吡唑-3-甲酸
|
K037011-100mg
|
96% |
129768-28-1 |
100mg
|
¥ 396.0
|
5-7天 |
科威 |
N-Boc-3-氨基-3-甲基丁酸
|
K037010-5g
|
≥97% |
129765-95-3 |
5g
|
¥ 2140.0
|
5-7天 |
科威 |
N-Boc-3-氨基-3-甲基丁酸
|
K037010-1g
|
≥97% |
129765-95-3 |
1g
|
¥ 713.0
|
5-7天 |
科威 |
(11aR)-3,7-Bis([1,1'-biphenyl]-4-yl)-10,11,12,13-tetrahydro-5-hydroxy-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin
|
K037009-100mg
|
≥98%,99%e.e. |
1297613-77-4 |
100mg
|
¥ 5505.0
|
5-7天 |
科威 |
(11aR)-3,7-Bis([1,1'-biphenyl]-4-yl)-10,11,12,13-tetrahydro-5-hydroxy-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin
|
K037009-50mg
|
≥98%,99%e.e. |
1297613-77-4 |
50mg
|
¥ 3854.0
|
5-7天 |
科威 |
(11aR)-3,7-Bis[3,5-bis(trifluoromethyl)phenyl]-10,11,12,13-tetrahydro-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin
|
K037008-100mg
|
≥98%,99%e.e. |
1297613-76-3 |
100mg
|
¥ 5197.0
|
5-7天 |
科威 |
(11aR)-3,7-Bis(3,5-dimethylphenyl)-10,11,12,13-tetrahydro-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin
|
K037007-100mg
|
≥98%,99%e.e. |
1297613-75-2 |
100mg
|
¥ 5200.0
|
5-7天 |
科威 |
(11aR)-10,11,12,13-Tetrahydro-5-hydroxy-3,7-di-2-naphthalenyl-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin
|
K037006-100mg
|
≥98%,99%e.e. |
1297613-74-1 |
100mg
|
¥ 5397.0
|
5-7天 |
科威 |
(11aR)-10,11,12,13-Tetrahydro-5-hydroxy-3,7-di-1-naphthalenyl-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin
|
K037005-100mg
|
≥98%,99%e.e. |
1297613-73-0 |
100mg
|
¥ 5403.0
|
5-7天 |
科威 |
(11aR)-10,11,12,13-Tetrahydro-5-hydroxy-3,7-diphenyl-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin
|
K037004-100mg
|
≥98%,99%e.e. |
1297613-72-9 |
100mg
|
¥ 4899.0
|
5-7天 |
科威 |
(R)-6,6'-Bis([1,1'-biphenyl]-4-yl)-2,2',3,3'-tetrahydro-1,1'-spirobi[1H-indene]-7,7'-diol
|
K037003-100mg
|
≥95%,99%e.e. |
1297613-71-8 |
100mg
|
¥ 5571.0
|
5-7天 |
科威 |
(R)-2,2',3,3'-Tetrahydro-6,6'-di(2-naphthalenyl)-1,1'-spirobi[1H-indene]-7,7'-diol
|
K037002-100mg
|
≥98%,99%e.e. |
1297613-70-7 |
100mg
|
¥ 4099.0
|
5-7天 |
科威 |
5-羟基甲基烟酸甲酯
|
K037001-250mg
|
97% |
129747-52-0 |
250mg
|
¥ 660.0
|
5-7天 |
科威 |
5-羟基甲基烟酸甲酯
|
K037001-50mg
|
97% |
129747-52-0 |
50mg
|
¥ 220.0
|
5-7天 |
科威 |
3-噻吩苯甲醛
|
K037000-100mg
|
95% |
129746-42-5 |
100mg
|
¥ 816.0
|
5-7天 |
科威 |
3-噻吩苯甲醛
|
K037000-25mg
|
95% |
129746-42-5 |
25mg
|
¥ 340.0
|
5-7天 |
科威 |
2-(3-氨基苯)乙酰胺
|
K036999-250mg
|
96% |
129743-47-1 |
250mg
|
¥ 949.0
|
5-7天 |
科威 |
2-(3-氨基苯)乙酰胺
|
K036999-50mg
|
96% |
129743-47-1 |
50mg
|
¥ 316.0
|
5-7天 |
科威 |
7-[4-[4-(2,3-二氯苯基)-1-哌嗪基]丁氧基]-2(1H)-喹啉酮
|
K036998-100mg
|
97% |
129722-25-4 |
100mg
|
¥ 1371.0
|
5-7天 |
科威 |
7-[4-[4-(2,3-二氯苯基)-1-哌嗪基]丁氧基]-2(1H)-喹啉酮
|
K036998-25mg
|
97% |
129722-25-4 |
25mg
|
¥ 571.0
|
5-7天 |
科威 |
6-溴喹啉-3-甲酰胺
|
K036997-50mg
|
97% |
1296950-96-3 |
50mg
|
¥ 970.0
|
5-7天 |
科威 |
6-溴-3,4-二氢-1H-[1,8]萘啶-2-酮
|
K036996-1g
|
95% |
129686-16-4 |
1g
|
¥ 1035.0
|
5-7天 |
科威 |